Northwestern Mutual Wealth Management Co. Has $5.65 Million Position in HCA Healthcare, Inc. $HCA

Northwestern Mutual Wealth Management Co. boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 13.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,758 shares of the company’s stock after acquiring an additional 1,713 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in HCA Healthcare were worth $5,654,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HCA. Saudi Central Bank bought a new position in shares of HCA Healthcare during the first quarter worth about $26,000. WPG Advisers LLC bought a new position in HCA Healthcare during the 1st quarter worth approximately $27,000. Ameriflex Group Inc. bought a new stake in shares of HCA Healthcare in the 2nd quarter valued at $27,000. Chung Wu Investment Group LLC acquired a new position in HCA Healthcare in the second quarter valued at $27,000. Finally, Clearstead Trust LLC grew its holdings in HCA Healthcare by 311.8% during the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after acquiring an additional 53 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This trade represents a 52.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 1.30% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on HCA shares. Raymond James Financial set a $525.00 target price on HCA Healthcare in a research note on Monday, October 27th. Barclays lifted their price objective on shares of HCA Healthcare from $445.00 to $494.00 and gave the company an “overweight” rating in a research note on Monday, October 27th. Mizuho raised their price target on shares of HCA Healthcare from $475.00 to $505.00 and gave the stock an “outperform” rating in a report on Monday, October 27th. Truist Financial increased their price objective on shares of HCA Healthcare from $460.00 to $495.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Finally, Morgan Stanley set a $425.00 price target on HCA Healthcare in a report on Monday, October 27th. Fourteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $474.53.

HCA Healthcare Stock Performance

HCA stock opened at $499.59 on Wednesday. The company has a market capitalization of $114.00 billion, a P/E ratio of 19.31, a price-to-earnings-growth ratio of 1.38 and a beta of 1.36. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $520.00. The business has a 50-day simple moving average of $455.78 and a two-hundred day simple moving average of $408.28.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The company had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter last year, the company earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.13%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.